A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia. Cappellini MD, Viprakasit V, Taher AT, Georgiev P, et al. N Engl J Med 2020;382:1219-1231.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cappellini MD, Viprakasit V, Taher AT, Georgiev P, et al. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia. N Engl J Med 2020;382:1219-1231.
PMID: 32212518